4.6 Article

Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign?

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 206, 期 -, 页码 158-163

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2016.01.042

关键词

Congenital heart defects; Ventricular tachyarrhythmia; Implantable cardioverter defibrillator

资金

  1. Erasmus Medical Center fellowship
  2. Dutch Heart Foundation [2011T046, 2013T144, 2013T096]
  3. CoolSingel Foundation [212]
  4. LSH-Impulse grant [40-43100-98-008]
  5. Bayer and Boehringer Ingelheim

向作者/读者索取更多资源

Background: Sustained ventricular tachycardia (susVT) and ventricular fibrillation (VF) are observed in adult patients with congenital heart disease (CHD). These dysrhythmias may be preceded by non-sustained ventricular tachycardia (NSVT). The aims of this study are to examine the 1] time course of ventricular tachyarrhythmia (VTA) in a large cohort of patients with various CHDs and 2] the development of susVT/VF after NSVT. Methods: In this retrospective study, patients with VTA on ECG, 24-hour Holter or ICD-printout or an out-of-hospital- cardiac arrest due to VF were included. In patients with an ICD, the number of shocks was studied. Results: Patients (N = 145 patients, 59% male) initially presented with NSVT (N = 103), susVT (N = 25) or VF (N = 17) at a mean age of 40 +/- 14 years. Prior to VTA, 58 patients had intraventricular conduction delay, 14 an impaired ventricular dysfunction and 3 had coronary artery disease. susVT/VF rarely occurred in patients with NSVT (N = 5). Fifty-two (36%) patients received an ICD; appropriate and inappropriate shocks, mainly due to supraventricular tachycardia (SVT), occurred in respectively 15 (29%) (NSVT: N = 1, susVT: N = 9, VF: N = 5) and 12 (23%) (NSVT: N = 4, susVT: N = 5, VF: N = 3) patients. Conclusions: VTA in patients with CHD appear on average at the age of 40 years. susVT/VF rarely developed in patients with only NSVT, whereas recurrent episodes of susVT/VF frequently developed in patients initially presenting with susVT/VF. Hence, a wait-and-see treatment strategy in patients with NSVT and aggressive therapy of both episodes of VTA and SVT in patients with susVT/VF seems justified. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据